|
| |
Sanofi-Synthelabo Pharmaceuticals in New York. Pages on BioPortfolio:
BioPortfolio - Sanofi-Synthelabo Pharmaceuticals Incorporated
Sanofi-Synthelabo Pharmaceuticals Incorporated - Entry on Bioportfolio's Biocorporate ... New York. NY. 10016. United States of America. Tel: 212 551
4292 ...
http://www.bioportfolio.com/biocorporate/9152-Sanofi-Synthel...
|
BioPortfolio Biotechnology BioNews : live article
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, ... NEW YORK, June 18 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - synthelabo pharmaceuticals
NEW YORK, November 11, 1999 - ICN Pharmaceuticals, Inc. (NYSE: ICN) today announced that an agreement has been reached with Sanofi-Synthelabo and Almirall
. ...
http://www.bioportfolio.com/search/synthelabo_pharmaceutical...
|
BioPortfolio - Sanofi Pharmaceuticals Incorporated
Sanofi Pharmaceuticals are the U.S. subsidiary of Sanofi-Synthelabo, ... New York. NY. 10016. United States of America. Tel: 212 551 4105. Fax: 212 551 4908
...
http://www.bioportfolio.com/biocorporate/9147-Sanofi_Pharmac...
|
BioPortfolio - Genzyme Genetics and assay
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery .... Dr Dong: Genzyme Genetics, 521 W 57th St, New York, NY . ...
http://www.bioportfolio.com/search/_Genzyme_Genetics__and__a...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science .... Malvern Kinexus ‘redefines the rheometer’ Radical new platform designed from ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Sanofi-Synthelabo Pharmaceuticals Incorporated
Sanofi-Synthelabo Pharmaceuticals Incorporated - Entry on Bioportfolio's Biocorporate ... New York. NY. 10016. United States of America. Tel: 212 551
4292 ...
http://www.bioportfolio.com/biocorporate/9152-Sanofi-Synthel...
|
BioSpace - Sanofi-Synthelabo News, Search Jobs, Events
19 Oct 2005 ... Sanofi-Synthelabo New York Division 90 Park Avenue ... the principle area of business of Sanofi-Synthelabo is ethical pharmaceuticals. ...
http://www.biospace.com/company_profile.aspx?CompanyID=3581...
|
Sanofi-Synthelabo Announces Its Listing on the New York Stock Exchange
The Sanofi-Synthelabo ADR will trade under the ticker symbol "SNY" and will represent one half of one ordinary share. The Bank of New York will act as the
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioPortfolio - synthelabo pharmaceuticals
NEW YORK, November 11, 1999 - ICN Pharmaceuticals, Inc. (NYSE: ICN) today announced that an agreement has been reached with Sanofi-Synthelabo and Almirall
. ...
http://www.bioportfolio.com/search/synthelabo_pharmaceutical...
|
Sanofi-Synthelabo Launches New U.S. Web Site
NEW YORK, April 19 /PRNewswire-FirstCall/ -- Today Sanofi-Synthelabo Inc., ... Sanofi-Synthelabo is a major global research-based pharmaceutical group with ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Therapeutic Challenges in the Treatment of Cardiovascular Diseases ...
Ltd, AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc., Bayer Corporation, Bristol-Myers ... Mount Sinai School of Medicine, New York, New
York ...
http://www.medscape.com/viewprogram/2891_authors...
|
Sanofi-Synthelabo to Expand U.S. Sales Force; New Additions to ...
NEW YORK, April 3 /PRNewswire/ -- Sanofi-Synthelabo Inc., ... Sanofi-Synthelabo is a worldwide pharmaceutical company with 30000 employees in 100 countries. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
The GI Cancer Challenge: Establishing Treatment Strategies Within ...
... Memorial Hospital, New York, New York Disclosure: Grants/Research Support: Aventis Pharmaceuticals Inc., Pfizer Inc; Consultant: Sanofi-Synthelabo, ...
http://www.medscape.com/viewprogram/3244_authors...
|
Sanofi-Synthelabo Names Tim Rothwell as New Head of North America ...
PARIS, April 22 /PRNewswire/ -- Sanofi-Synthelabo has named Timothy Rothwell as President and CEO of Sanofi-Synthelabo, Inc. based in New York City, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Practice Implications of Recent Hypertension and Lipid Trials ...
Consultant: Bristol-Myers Squibb Company, BioVail, Merck & Co, Inc, Novartis Pharmaceuticals, Pfizer Inc, Reliant, Sanofi-Synthelabo Inc, The Salt Institute
...
http://www.medscape.com/viewprogram/2494_authors...
|
|
